# PD-L1-expressing Regulatory T Cells in Localized Prostate Cancer Patients Undergoing Iodine-125 Permanent Brachytherapy

> **NCT04369508** · — · UNKNOWN · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 20 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** permanent brachytherapy

## Key facts

- **NCT ID:** NCT04369508
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04369508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04369508, "PD-L1-expressing Regulatory T Cells in Localized Prostate Cancer Patients Undergoing Iodine-125 Permanent Brachytherapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04369508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*